State Street
OTLK icon

State Street’s Outlook Therapeutics OTLK Stock Holding History

State Street’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33.6K Hold
163,102
– – ﹤0.01% 4173
2025
Q4 		$258K Buy
163,102
+87,800
+117% +$140K ﹤0.01% 3838
2025
Q3 		$79.8K Sell
75,302
-10,150
-12% -$17.6K ﹤0.01% 4089
2025
Q2 		$137K Sell
85,452
-202,808
-70% -$323K ﹤0.01% 3917
2025
Q1 		$352K Buy
288,260
+39,664
+16% +$69.5K ﹤0.01% 3685
2024
Q4 		$470K Buy
248,596
+16,054
+7% +$66K ﹤0.01% 3636
2024
Q3 		$1.24M Buy
232,542
+21,201
+10% +$155K ﹤0.01% 3446
2024
Q2 		$1.56M Buy
211,341
+61,225
+41% +$492K ﹤0.01% 3393
2024
Q1 		$1.79M Buy
150,116
+8,791
+6% +$71.1K ﹤0.01% 3311
2023
Q4 		$1.11M Buy
141,325
+1,836
+1% +$15.5K ﹤0.01% 3465
2023
Q3 		$617K Buy
139,489
+1,890
+1% +$41.8K ﹤0.01% 3623
2023
Q2 		$4.79M Buy
137,599
+36,596
+36% +$998K ﹤0.01% 3015
2023
Q1 		$2.2M Buy
101,003
+5,019
+5% +$112K ﹤0.01% 3308
2022
Q4 		$2.07M Sell
95,984
-1,469
-2% -$32K ﹤0.01% 3364
2022
Q3 		$2.38M Buy
97,453
+2,986
+3% +$69.4K ﹤0.01% 3365
2022
Q2 		$1.93M Buy
94,467
+11,114
+13% +$320K ﹤0.01% 3491
2022
Q1 		$2.97M Buy
83,353
+4,965
+6% +$155K ﹤0.01% 3418
2021
Q4 		$2.13M Buy
78,388
+154
+0.2% +$5.49K ﹤0.01% 3613
2021
Q3 		$3.4M Buy
78,234
+11,108
+17% +$536K ﹤0.01% 3431
2021
Q2 		$3.34M Buy
+67,126
New +$3.11M ﹤0.01% 3418

Other funds holding OTLK

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $126M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NMC
Nine Masts Capital Central, Hong Kong $693M AUM 31.93% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

State Street's OTLK Position: Q1 2026 in Review

State Street held its Outlook Therapeutics (OTLK) position steady in Q1 2026 at 163,102 shares worth $33.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4173.

State Street first reported a position in OTLK in Q2 2021 and has held it in 20 quarters since. The position peaked at $4.79M in Q2 2023. 54 funds tracked by Wall St. Rank hold OTLK as of Q1 2026.

  • State Street held 163,102 shares of Outlook Therapeutics worth $33.6K as of Q1 2026.
  • State Street left its Outlook Therapeutics share count unchanged in Q1 2026.
  • Outlook Therapeutics made up ﹤0.01% of State Street's portfolio in Q1 2026, its #4173 holding.
  • State Street first reported a position in Outlook Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • State Street's Outlook Therapeutics position peaked at $4.79M in Q2 2023.
  • 54 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.